Evidence map›Paper›PMID 40505961›Full record

ArticleCanadian journal of diabetes2025

A Pilot Study of the Feasibility and Acceptability of a Patient Navigator in a Pediatric Type 1 Diabetes Clinic.

Elise Schlissel Tremblay, Ashley B Tartarilla, Kali McCollister, Mia Umali, Melicia Y Whitley, Julia Ainsworth, Patrice Melvin, Lori M Laffel, Valerie L Ward

Abstract read
In one paragraph

Article in Canadian journal of diabetes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elise Schlissel TremblayDivision of Endocrinology, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, United States; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States. Electronic address: elise.tremblay@childrens.harvard.edu.
Ashley B TartarillaSandra L. Fenwick Institute for Pediatric Health Equity and Inclusion, Boston Children's Hospital, Boston, Massachusetts, United States.
Kali McCollisterSandra L. Fenwick Institute for Pediatric Health Equity and Inclusion, Boston Children's Hospital, Boston, Massachusetts, United States.
Mia UmaliSandra L. Fenwick Institute for Pediatric Health Equity and Inclusion, Boston Children's Hospital, Boston, Massachusetts, United States.
Melicia Y WhitleySandra L. Fenwick Institute for Pediatric Health Equity and Inclusion, Boston Children's Hospital, Boston, Massachusetts, United States.
Julia AinsworthSandra L. Fenwick Institute for Pediatric Health Equity and Inclusion, Boston Children's Hospital, Boston, Massachusetts, United States.
Patrice MelvinSandra L. Fenwick Institute for Pediatric Health Equity and Inclusion, Boston Children's Hospital, Boston, Massachusetts, United States.
Lori M LaffelDivision of Endocrinology, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, United States; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States; Joslin Diabetes Center, Boston, Massachusetts, United States.
Valerie L WardDepartment of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States; Sandra L. Fenwick Institute for Pediatric Health Equity and Inclusion, Boston Children's Hospital, Boston, Massachusetts, United States; Department of Pediatric Radiology, Boston Children's Hospital, Boston, Massachusetts, United States.

Funding

Optimizing Use of Continuous Glucose Monitoring (CGM) to Improve Care for Youth with Type 1 Diabetes K23DK133685 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI Elise Schlissel Tremblay · 2023 to 2026
$774k
NIDDK NIH HHS K23 DK133685
6 · The paper itself

Abstract

objectiveOur aim in this study was to assess the feasibility and acceptability of a patient navigator (PN) in a pediatric type 1 diabetes (T1D) clinic.

methodsWe conducted a pilot prospective cohort intervention study from 2022 to 2024 of pediatric endocrinology patients with T1D of ≥1-year duration with glycated hemoglobin (A1C) ≥9.0%. Participants met with a PN over 6 months of clinic visits that consisted of pre- and postclinic visits to establish both clinical and nonclinical needs and follow-up goals. A subset of families completed semistructured interviews after the 6-month intervention to characterize their experiences during the study.

resultsOf 118 eligible patients, 27 youth of diverse backgrounds and their caregivers enrolled and 17 completed the study. Five or more distinct needs or goals were identified by ≥50% of families before as well as after clinic visits. Health-related social needs/concerns were identified at ∼20% of PN and clinic visits. After the 6-month study, 3 main themes emerged during the interviews: appreciation for the added value of a PN to support diabetes visits; recognition and gratitude for the efficiency of PN contacts; and a preference to personalize the PN intervention to family needs.

conclusionsIn this pilot study we demonstrated a high level of need among families of youth with T1D with suboptimal glycemic management; however, challenges with recruitment and retention demonstrated the importance of tailoring of the PN intervention to family priorities. Further study is required to optimize the impact of a PN in pediatric T1D clinics, with potential implementation at the time of diagnosis when there is need for greater support.

Indexed as

Diabetes Mellitus, Type 1Patient Acceptance of Health CarePatient NavigationAdolescentAmbulatory Care FacilitiesChildFeasibility StudiesFemaleFollow-Up StudiesGlycated HemoglobinHumansMalePilot ProjectsProspective StudiesGlycated Hemoglobinbesoins sociaux liés à la santédiabète de type 1disparités dans les soins de santéguide accompagnateur pour les patientshealth-care disparitieshealth inequitieshealth-related social needsinégalités en santépatient navigatorpediatricspédiatrietype 1 diabetes

Identifiers

PMID40505961
PMCPMC13014301

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.